Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for phosphatidylinositol 3- kinases
Most Correlated Studies
- Mantle cell lymphoma (MCL) cells treated with kinase inhibitors
- Human breast cancer cell (T47D) gene expression after treatment with GDC-0941
- HCT116 colorectal carcinoma cells in the presence and absence of tumor suppressor PTEN
- Rcho-1 trophoblast stem cell gene expression after differentiation with or without LY294002
- Embryonic stem cells with Gsk-3a and Gsk-3b double knockout
Most Relevant Literature
- Dual Activity of Type III PI3K Kinase Vps34 is Critical for NK Cell Development and Senescence.
- Pik3c3 expression profiling in the mouse kidney and its role in proximal tubule cell physiology.
- Lack of phosphatidylinositol 3-kinase VPS34 in regulatory T cells leads to a fatal lymphoproliferati…
- Vps34 sustains Treg cell survival and function via regulating intracellular redox homeostasis.
- Lipid kinase PIK3C3 maintains healthy brown and white adipose tissues to prevent metabolic diseases.
Most Relevant Clinical Trials
- Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer
- Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglo…
- Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patie…
- Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cispla…
- A Prospective Multicenter Phase 2 Study of the Chemotherapy-Free Combination of the Intravenous Phos…
